Clinical trials
Active, not recruiting Phase 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,949 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 13 |
| 2011 | 14 |
| 2012 | 12 |
| 2013 | 18 |
| 2014 | 36 |
| 2015 | 39 |
| 2016 | 56 |
| 2017 | 81 |
| 2018 | 88 |
| 2019 | 133 |
| 2020 | 138 |
| 2021 | 184 |
| 2022 | 234 |
| 2023 | 256 |
| 2024 | 247 |
| 2025 | 268 |
| 2026 | 109 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1,949 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 102 |
| M.D. Anderson Cancer Center | 66 |
| Memorial Sloan Kettering Cancer Center | 65 |
| City of Hope Medical Center | 56 |
| AbbVie | 28 |
| Dana-Farber Cancer Institute | 27 |
| Baylor College of Medicine | 26 |
| University of Pennsylvania | 25 |
| Janssen Research & Development, LLC | 24 |
| AstraZeneca | 23 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 104 |
| Breast Neoplasms | 92 |
| Neoplasms | 80 |
| Melanoma | 67 |
| Neoplasm Metastasis | 65 |
| Leukemia, Myeloid, Acute | 64 |
| Colorectal Neoplasms | 63 |
| Prostatic Neoplasms | 62 |
| Glioblastoma | 60 |
| Ovarian Neoplasms | 60 |
Trials
Showing 26 to 50 of 1,949. Each trial links to its page on Pharma Observatory.
1,849 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.